Poniard Pharmaceuticals (PARD)
OTHER OTC:PARD
US Market
Holding PARD?
Track your performance easily

Poniard Pharmaceuticals (PARD) Financial Statements

8 Followers

Poniard Pharmaceuticals Financial Overview

Poniard Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Poniard Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 11Jun 11Mar 11Dec 10Sep 10
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
EBIT$ -3.75M$ -3.84M$ -3.23M$ -4.71M$ -5.95M
EBITDA$ -3.44M$ -3.52M$ -2.91M$ -4.39M$ -5.62M
Net Income Common Stockholders$ -3.82M$ -3.91M$ -3.29M$ -5.21M$ -6.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.98M$ 3.69M$ 5.47M$ 4.33M$ 23.34M
Total Assets$ 7.74M$ 9.99M$ 12.22M$ 11.64M$ 31.14M
Total Debt$ 1.64M$ 1.62M$ 1.60M$ 1.57M$ 14.47M
Net Debt$ -344.00K$ -2.07M$ -3.88M$ -2.76M$ -8.87M
Total Liabilities$ 4.62M$ 3.71M$ 2.88M$ 3.19M$ 19.01M
Stockholders Equity$ 3.12M$ 6.28M$ 9.34M$ 8.45M$ 12.13M
Cash Flow-
Free Cash Flow$ -1.71M$ -1.68M$ -2.03M$ -5.05M$ -3.88M
Operating Cash Flow$ -1.71M$ -1.68M$ -2.02M$ -5.05M$ -3.87M
Investing Cash Flow$ 0.00$ -2.00K$ 3.02M$ 9.21M$ 6.66M
Financing Cash Flow$ 0.00$ -96.00K$ 3.18M$ -13.89M$ -1.97M
Currency in USD

Poniard Pharmaceuticals Earnings and Revenue History

Poniard Pharmaceuticals Debt to Assets

Poniard Pharmaceuticals Cash Flow

Poniard Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis